ArticleEClinicalMedicine2025
Prediction model for type 2 diabetes mellitus and its association with mortality using machine learning in three independent cohorts from South Korea, Japan, and the UK: a model development and validation study.
Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Multioutput Machine Learning Model for Predicting Postoperative Outcomes After Liposuction: Algorithm Development and Validation Study in a Multicenter Cohort.JMIR medical informatics · 2026Article
- Machine Learning Prediction Model for Dyslipidemia and Its Association With Atherothrombotic Events in 3 Independent Cohorts From South Korea, Japan, and the United Kingdom: Algorithm Development and Validation Study.JMIR medical informatics · 2026Article
- An interpretable progressive residual network for automated multiclass diabetes diagnosis.Scientific reports · 2026Article
- Development and validation of a prediction model for respiratory complications and in-hospital mortality in trauma patients.Scientific reports · 2026Article
- Development and validation of an explainable machine learning model for differentiating diabetic nephropathy from diabetic retinopathy in patients with type 2 diabetes.Frontiers in endocrinology · 2026Article
- Predicting cardiometabolic multimorbidity trajectory in middle-aged and older Chinese adults: insights from the cohort study on global ageing and adult health.Frontiers in medicine · 2026Article
- Early Type 2 diabetes risk prediction using explainable machine learning in a two-stage approach.Frontiers in digital health · 2026Article
- Machine-learning-based prediction model of type 2 diabetes using liver enzymes: a cross-sectional study.Frontiers in endocrinology · 2026Article
- On-scene machine learning prediction model for massive transfusion in trauma and its association with in-hospital mortality.BJS open · 2025Article
- Machine Learning Based Identification of Depressive Symptoms Among Students in a Chinese University Using Functional Near-Infrared Spectroscopy.Alpha psychiatry · 2025Article
- Multimodal and Multidimensional Artificial Intelligence Technology in Obesity.Journal of obesity & metabolic syndrome · 2025Review
- Sex-Specific Dietary Predictors of Blood Glucose Identified Through Decision Tree Modeling in Adults.Nutrients · 2025Article
- Sex- and age-specific determinants of diabetes: Insights from BKMR and cox modelling of metabolic and lifestyle risk factors in a Korean cohort.Diabetes, obesity & metabolism · 2025Article
- Development and validation of an interpretable multi-task model to predict outcomes in patients with rhabdomyolysis: a multicenter retrospective cohort study.EClinicalMedicine · 2025Article
- Development of an early prediction model for risk of influenza A and influenza B based on complete blood count examination.BMC infectious diseases · 2025Article
- Family history of non-communicable diseases and the risk of cardiovascular-kidney-metabolic syndrome.Scientific reports · 2025Article
- Development and internal validation of a machine learning algorithm for the risk of type 2 diabetes mellitus in children with obesity.Frontiers in endocrinology · 2025Article
- Type 2 diabetes prediction without labs: a systems-level neural framework for risk and behavioral network reorganization.Frontiers in digital health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type 2 diabetes mellitus (T2DM) is a significant global public health concern that has steadily increased over the past few decades. Thus, this study aimed to predict the incidence of T2DM within 5 years and the risk of mortality following the onset of T2DM. Data from three independent cohorts worldwide were used. Methods: We utilized data from three independent, large-scale, general population-based, and worldwide cohort studies. The Korean cohort (NHIS-NSC cohort; discovery cohort; n = 973,303), conducted between 1 January, 2002 and 31 December, 2013, was used for training and internal validation, whereas the Japanese cohort (JMDC cohort; validation cohort A; n = 12,143,715) and UK cohort (UK Biobank; validation cohort B; n = 416,656) were used for external validation. We employed various machine learning (ML)-based models, using 18 features, to predict the incidence of T2DM within five years of regular health checkups and calculated the Shapley Additive Explanation (SHAP) values. To ensure the robustness of our ML-based prediction model, we investigated the potential association between the model probability divided into tertiles and the risk of mortality following the onset of T2DM. Findings: In the discovery cohort, the ensemble model using voting with logistic regression and adaptive boosting achieved a balanced accuracy of 72.6% and an area under the receiver operating characteristics curve (AUROC) of 0.792. The SHAP value analysis of our proposed model revealed that age was the most important predictor of incident T2DM, followed by fasting blood glucose, hemoglobin, γ-glutamyl transferase level, and body mass index. The model probability is associated with an increased risk of mortality (T1: adjusted hazard ratio, 2.82 [95% CI, 2.01-3.94]; T2: 3.89 [2.74-5.53]; and T3: 7.73 [5.37-11.12]). Similar patterns and trends were observed in the validation cohorts (T1: 1.74 [1.49-2.03], T2: 1.97 [1.69-2.30], and T3: 3.31 [2.82-3.38] in validation cohort A; T1: 1.33 [1.03-1.71], T2: 1.54 [1.21-1.96], and T3: 1.73 [1.36-2.20] in validation cohort B). Interpretation: This study derived and validated an ML-based model to predict the incidence of T2DM within 5 years across three countries (South Korea, Japan, and the UK), showing that the model probability is associated with an increased risk of mortality. Funding: Institute of Information & Communications Technology Planning & Evaluation, South Korea.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.